AAA

AROA BIOSURGERY LIMITED

No trades
See on Supercharts
Market capitalization
‪172.10 M‬AUD
−0.020AUD
‪−360.81 K‬AUD
‪57.73 M‬AUD
‪233.27 M‬
Beta (1Y)
0.35

About AROA BIOSURGERY LIMITED

CEO
Brian Roderick Ward
Website
Headquarters
Mangere
Founded
2008
ISIN
NZARXE0001S1
FIGI
BBG00VX929P6
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARX is 0.500 AUD — it has decreased by 0.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AROA BIOSURGERY LIMITED stocks are traded under the ticker ARX.
AROA BIOSURGERY LIMITED is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ARX stock is 3.00% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is AROA BIOSURGERY LIMITED there?
ARX earnings for the last quarter are −0.01 AUD per share, whereas the estimation was −0.01 AUD resulting in a −14.29% surprise. The estimated earnings for the next quarter are −0.01 AUD per share. See more details about AROA BIOSURGERY LIMITED earnings.
AROA BIOSURGERY LIMITED revenue for the last quarter amounts to ‪31.07 M‬ AUD despite the estimated figure of ‪30.69 M‬ AUD. In the next quarter revenue is expected to reach ‪30.75 M‬ AUD.
Yes, you can track AROA BIOSURGERY LIMITED financials in yearly and quarterly reports right on TradingView.
ARX stock has fallen by 8.26% compared to the previous week, the month change is a 12.28% fall, over the last year AROA BIOSURGERY LIMITED has showed a 52.83% decrease.
ARX net income for the last quarter is ‪−5.83 M‬ AUD, while the quarter before that showed ‪−1.82 M‬ AUD of net income which accounts for −219.86% change. Track more AROA BIOSURGERY LIMITED financial stats to get the full picture.
Today AROA BIOSURGERY LIMITED has the market capitalization of ‪173.83 M‬, it has decreased by 7.41% over the last week.
No, ARX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROA BIOSURGERY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
ARX reached its all-time high on Jul 30, 2020 with the price of 1.745 AUD, and its all-time low was 0.490 AUD and was reached on Mar 19, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AROA BIOSURGERY LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AROA BIOSURGERY LIMITED stock shows the sell signal. See more of AROA BIOSURGERY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AROA BIOSURGERY LIMITED future price: according to them, ARX price has a max estimate of 1.20 AUD and a min estimate of 0.89 AUD. Read a more detailed AROA BIOSURGERY LIMITED forecast: see what analysts think of AROA BIOSURGERY LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AROA BIOSURGERY LIMITED EBITDA is ‪−5.02 M‬ AUD, and current EBITDA margin is −1.59%. See more stats in AROA BIOSURGERY LIMITED financial statements.